Pathogenic alterations in PIK3CA and KMT2C are frequent and independent prognostic factors in anal squamous cell carcinoma treated with salvage …

A Hamza, J Masliah‐Planchon… - … Journal of Cancer, 2024 - Wiley Online Library
The management of anal squamous cell carcinoma (ASCC) has yet to experience the
transformative impact of precision medicine. Conducting genomic analyses may uncover …
被引用次数：2 相关文章

Pathogenic alterations in PIK3CA and KMT2C are frequent and independent prognostic factors in anal squamous cell carcinoma treated with salvage …

A Hamza, J Masliah-Planchon… - … Journal of Cancer, 2024 - hal-obspm.ccsd.cnrs.fr
The management of anal squamous cell carcinoma (ASCC) has yet to experience the
transformative impact of precision medicine. Conducting genomic analyses may uncover …

Pathogenic alterations in PIK3CA and KMT2C are frequent and independent prognostic factors in anal squamous cell carcinoma treated with salvage …

A Hamza, J Masliah-Planchon… - … Journal of Cancer, 2024 - univ-rennes.hal.science
The management of anal squamous cell carcinoma (ASCC) has yet to experience the
transformative impact of precision medicine. Conducting genomic analyses may uncover …

Pathogenic alterations in PIK3CA and KMT2C are frequent and independent prognostic factors in anal squamous cell carcinoma treated with salvage …

A Hamza, J Masliah-Planchon, C Neuzillet… - … Journal of Cancer, 2023 - europepmc.org
The management of anal squamous cell carcinoma (ASCC) has yet to experience the
transformative impact of precision medicine. Conducting genomic analyses may uncover …

Pathogenic alterations in PIK3CA and KMT2C are frequent and independent prognostic factors in anal squamous cell carcinoma treated with salvage …

A Hamza, J Masliah-Planchon, C Neuzillet… - International Journal of …, 2024 - hal.univ-smb.fr
The management of anal squamous cell carcinoma (ASCC) has yet to experience the
transformative impact of precision medicine. Conducting genomic analyses may uncover …

Pathogenic alterations in PIK3CA and KMT2C are frequent and independent prognostic factors in anal squamous cell carcinoma treated with salvage …

A Hamza, J Masliah-Planchon, C Neuzillet… - International Journal of …, 2023 - hal.science
The management of anal squamous cell carcinoma (ASCC) has yet to experience the
transformative impact of precision medicine. Conducting genomic analyses may uncover …

Pathogenic alterations in PIK3CA and KMT2C are frequent and independent prognostic factors in anal squamous cell carcinoma treated with salvage …

A Hamza, J Masliah-Planchon… - … Journal of Cancer, 2024 - hal.insa-toulouse.fr
The management of anal squamous cell carcinoma (ASCC) has yet to experience the
transformative impact of precision medicine. Conducting genomic analyses may uncover …

Pathogenic alterations in PIK3CA and KMT2C are frequent and independent prognostic factors in anal squamous cell carcinoma treated with salvage …

A Hamza, J Masliah-Planchon… - … Journal of Cancer, 2024 - u-paris.hal.science
The management of anal squamous cell carcinoma (ASCC) has yet to experience the
transformative impact of precision medicine. Conducting genomic analyses may uncover …

Pathogenic alterations in PIK3CA and KMT2C are frequent and independent prognostic factors in anal squamous cell carcinoma treated with salvage …

A Hamza, J Masliah-Planchon… - … Journal of Cancer, 2024 - hal-emse.ccsd.cnrs.fr
The management of anal squamous cell carcinoma (ASCC) has yet to experience the
transformative impact of precision medicine. Conducting genomic analyses may uncover …

Pathogenic alterations in PIK3CA and KMT2C are frequent and independent prognostic factors in anal squamous cell carcinoma treated with salvage …

A Hamza, J Masliah-Planchon, C Neuzillet… - … Journal of Cancer, 2024 - inria.hal.science
The management of anal squamous cell carcinoma (ASCC) has yet to experience the
transformative impact of precision medicine. Conducting genomic analyses may uncover …